Skip to main navigation
  • About
    • Our Vision
    • Our Approach
    • Our Team
  • Pipeline
    • DARE-BV1
    • OVAPRENE®
    • Sildenafil Cream, 3.6%
  • Partners
  • Consumers
  • Investors
    • Overview
    • Press Releases
    • Presentation, Events & Webcasts
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Analyst Coverage
    • Financial Information
      • Financials Overview
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management
    • Contact
  • Careers
  • Contact Us
    Dare Biosciences
    • Investors
    • Press releases
    • Presentations, Events & Webcasts
    • Stock information
    • Financial Information
    • Corporate governance
    • Contact

    SEC Filing Details

    SEC Filing Details

    Document Details

    Form
    424B5
    Filing Date
    Aug 30, 2023
    Document Date
    Aug 30, 2023
    Form Description
    Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
    Filing Group
    Registration Statements
    Company
    Daré Bioscience
    Issuer
    DARE BIOSCIENCE, INC.

    Filing Formats

    View HTML
    Download PDF
    Download DOC
    Download XLS
    • Request email alerts |
    • Print this page |
    • Search investor site |

    © 2023 by Daré Bioscience | Daré Bioscience® is a registered trademark of Daré Bioscience, Inc.

    Privacy Policy | Terms of Service | COI Policy |

    Scroll to top